TP53 and cholangiocarcinoma: The Cancer Genome Atlas (TCGA) scientists also discovered that gain of function mutations in the TP53 and PTEN oncogenes and loss of functions mutations in the BRAF and KRAS proto-oncogenes contribute to the development of cholangiocarcinoma [13].